Telerehabilitation Robotics for Upper Limb Rehabilitation After STroke
ConditionStroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-90
SponsorTan Tock Seng Hospital
About this trial
There has been an observed decrease in motor and functional ability and non-use of the impaired limb in chronic patients. This is due to the immediate drop in intensive daily therapy (5 days per week for 3 hours/day) that is usually provided during the inpatient (acute) phase upon discharge from the hospital.
In this study, the investigators plan to address the low dosage of therapy in the post-acute discharge phase for stroke survivors.
Eligibility criteria
Qualifiers
Clinical stroke (ischaemic or haemorrhagic) confirmed by admitting doctors and CT, CT angiography or MRI brain imaging.
Age 21 to 90 years, both males and females.
At least > 28 days post stroke.
Upper limb motor impairment of Fugl-Myer Motor Assessment (FMA) scale 10 to 60
Disqualifiers
Non-stroke related causes of arm motor impairment.
Medical conditions incompatible with research participation: uncontrolled medical illnesses (hypertension or diabetes, ischaemic heart disease, congestive heart failure, bronchial asthma, end stage renal/liver/heart/lung failure, unresolved cancers.
Anticipated life expectancy of < 6 months.
Inability to tolerate sitting continuously for 60 minutes.
Trial design
Treatments tested in this trial
- HMAN Robot
Treatment groups
54 Participants
are divided into 1 treatment groupSponsors and collaborators
Tan Tock Seng Hospital
Lead sponsor
National University Hospital, Singapore
Collaborator
Singapore General Hospital
Collaborator
Source ClinicalTrials.gov